Clinical trials: Inflammatory Bowel Diseases (IBD)
Crohn's Disease
Ciprofloxacin for the Prevention of Postoperative Endoscopic Recurrence in Crohn's Disease
Despite extensive medical treatment, surgical resection is required in approximately 70% of the patients at some time. However, recurrence of the disease after operation occurs in the majority of patients and is a serious…
- Trial name
- NCT00609973
- Testing
- Ciprofloxacin
- Where
- United States
- Volunteers
- 33 people
- Sponsor
- University of North Carolina, Chapel Hill
Ulcerative Colitis, Crohn Disease
Spatially and Temporally Resolving Predictive Biomarkers of Postoperative Recurrence and Complications in Chronic Intestinal Inflammation
A portion of patients with Inflammatory bowel disease often require surgical intervention since they do not respond to the current therapies.
- Trial name
- NCT06516341
- Testing
- CD patients, UC patients
- Where
- Italy
- Volunteers
- 35 people
- Sponsor
- IRCCS Ospedale San Raffaele
Ulcerative Colitis
A Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis
The purpose of this study is to compare the efficacy of visilizumab to placebo in subjects with intravenous steroid-refractory ulcerative colitis.
- Trial name
- NCT00279422
- Testing
- visilizumab
- Where
- 70 sites in United States, Australia and 12 more
- Volunteers
- 127 people
- Sponsor
- Facet Biotech
Abdominal Pain, Inflammatory Bowel Diseases
Examining the Effect of Ondansetron on Bowel Prep Success
This is a pilot randomized-controlled trial assessing the utility of ondansetron for improving pediatric pre-colonoscopy bowel prep outcomes using the boston bowel preparation score, as well as assessing the impact on patient…
- Conditions
- Abdominal Pain, Inflammatory Bowel Diseases, Eosinophilic Gastroenteritis, Diarrhea
- Trial name
- NCT05439772
- Testing
- Ondansetron
- Where
- United States
- Volunteers
- 41 people
- Sponsor
- State University of New York - Downstate Medical Center
Crohn's Disease, Ulcerative Colitis
Multispectral Optoacoustic Tomography (MSOT) for the Evaluation of Disease Activity in Inflammatory Bowel Diseases (IBD)
Monocentric, prospective interventional study to assess the degree of disease activity with a multispectral optoacoustic tomography (MSOT) handheld scanner in patients with Crohn's disease or ulcerative colitis.
- Conditions
- Crohn's Disease, Ulcerative Colitis, IBD
- Trial name
- MSOT_IBD (NCT02622139)
- Testing
- Multispectral Optoacoustic Tomography (MSOT)
- Where
- Germany
- Volunteers
- 344 people
- Sponsor
- University of Erlangen-Nürnberg Medical School
Crohn Disease
A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Crohn Disease
Dysbiosis can be rectified by several methods: antibiotics, prebiotics, probiotics, dietary modulation, and fecal microbiota transplantation.
- Trial name
- ALTER-CD (NCT06890650)
- Testing
- Fecal Microbial Transplantation, Crohns disease exclusion diet
- Where
- 6 sites in India
- Volunteers
- 168 people
- Sponsor
- All India Institute of Medical Sciences
Crohn Disease
Microbiome Modification to Enhance Stelara Response in Crohn's Disease
This pilot study is being completed to determine whether a low-serine diet vs a high serine diet will reduce inflammation and symptoms in Crohn's disease (CD), as well as determine whether a low-serine diet (vs.
- Trial name
- MIM-TESRIC (NCT04795960)
- Testing
- Low serine diet, High serine diet
- Where
- United States
- Sponsor
- University of Michigan
Inflammatory Bowel Diseases
Markers of Oxidative Stress in Inflammatory Bowel Diseases: Risk Factors and Implications for a Dietetic Approach
Inflammatory bowel disease (IBD), including Crohn's disease (CD), Ulcerative Colitis (UC) and IBD-unclassified (IBD-U) is a chronic inflammatory intestinal disorders that affect both children and adults.
- Trial name
- OxIBDiet (NCT04513015)
- Testing
- Antioxidant diet, Normal dietetic scheme
- Where
- 2 sites in Italy
- Volunteers
- 155 people
- Sponsor
- Università Politecnica delle Marche
Ulcerative Colitis (UC)
The Fecal Immunoassay Occult Blood Test Combined With Calprotectin Sequential Linkage Imaging Endoscopy Screening Strategy for Monitoring Tumor Changes Associated With Long-duration Ulcerative Colitis
Ulcerative colitis (UC) is a chronic inflammatory bowel disease associated with an increased risk of colorectal cancer, known as UC-associated neoplasia (UCAN).
- Trial name
- DETECT-UCAN (NCT07742410)
- Volunteers
- 250 people
- Sponsor
- Qilu Hospital of Shandong University
Iron Deficiency Anemia Secondary to IBD or Gastric Bypass
Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia (IDA) Secondary to Inflammatory Bowel Disease (IBD) or Gastric Bypass
The primary objective of this study is to evaluate the treatment response of Injectafer vs. oral iron to baseline hepcidin levels to determine if any of these select IBD or Gastric Bypass patients may demonstrate to be…
- Trial name
- NCT02086968
- Testing
- Injectafer, Ferrous Sulfate tablets
- Volunteers
- 198 people
- Sponsor
- American Regent, Inc.
Ulcerative Colitis (UC)
Selection and Efficacy-Influencing Factors of First-Line Biologic Agents in Moderate-to-Severe Ulcerative Colitis
The purpose of this prospective, multicenter, real-world study is to compare the efficacy differences and influencing factors of different first-line biologics in patients with moderate to severe ulcerative colitis.
- Trial name
- NCT06962020
- Testing
- first-line biologic：IFX, first-line biologic:VDZ
- Where
- China
- Volunteers
- 400 people
- Sponsor
- Xijing Hospital of Digestive Diseases
Ulcerative Colitis
Vitamin D and Disease Activity in Ulcerative Colitis
The purpose of this study is to test blood and tissue samples of people with Ulcerative Colitis (UC) to see what effects vitamin D may have on the immune system.
- Trial name
- NCT02717897
- Testing
- No intervention
- Volunteers
- 248 people
- Sponsor
- University of Chicago
Inflammatory Bowel Disease (IBD), Immunosuppressed or Non-Immunosuppressed
Impact of Immunosuppression in IBD Patients on Response to Influenza Vaccine
The purpose of this study is to compare the efficacy and safety of influenza vaccine in patients with inflammatory bowel disease (IBD) on immunosuppressive therapy with IBD patients on aminosalicylates and healthy historical…
- Conditions
- Inflammatory Bowel Disease (IBD), Immunosuppressed or Non-Immunosuppressed, Influenza Vaccine, Antibody Titers
- Trial name
- NCT00542776
- Testing
- blood draw
- Where
- United States
- Volunteers
- 146 people
- Sponsor
- Boston Children's Hospital
Crohn's Disease
The Efficacy of Low Dose Naltrexone Therapy in Children With Crohn's Disease
It is hypothesized that oral naltrexone will improve inflammation of the bowel by increasing endogenous enkephalin levels in subjects with active Crohn's disease.
- Trial name
- LDN-Ped (NCT00715117)
- Testing
- Naltrexone
- Where
- United States
- Volunteers
- 14 people
- Sponsor
- Milton S. Hershey Medical Center
Crohns Disease, Ulcerative Colitis
Integrative Gastroenterology - an Observational Trial
This study aims to test, if a two-week integrative therapy in an internal medicine ward will improve symptoms, disability and quality of life in patients with inflammatory bowel disease or irritable bowel syndrome.a It shall…
- Conditions
- Crohns Disease, Ulcerative Colitis, Irritable Bowel Syndrome
- Trial name
- InteGast (NCT02476643)
- Testing
- Integrative Therapy
- Where
- Germany
- Volunteers
- 200 people
- Sponsor
- Universität Duisburg-Essen
Crohn's Disease
Artificial Intelligence-Based Classification and Prognostic Prediction in Small Bowel Crohn's Disease
This retrospective observational study aims to develop an artificial intelligence-based system for the precise classification and prognostic prediction of small bowel Crohn's disease.
- Trial name
- NCT07757217
- Testing
- Artificial Intelligence-Based Multimodal Analysis
- Where
- China
- Volunteers
- 437 people
- Sponsor
- Shanghai 10th People's Hospital
Colonic Neoplasms, Diverticulosis, Colonic
Biodegradable Stenting Anastomoses Versus Double-layer Hand Sutures for Reconstruction in Intestinal Anastomosis
Intestinal anastomosis plays an important role in various general surgeries, but the complications such as anastomotic leakage,stenosis and hemorrhage cannot been avoided.
- Conditions
- Colonic Neoplasms, Diverticulosis, Colonic, Crohn Disease
- Trial name
- NCT02752360
- Testing
- Biodegradable Stenting Anastomoses, Double-layer Hand Sutures
- Where
- China
- Volunteers
- 288 people
- Sponsor
- Beijing Friendship Hospital
Crohn Disease
MeSenteric SpAring Versus High Ligation Ileocolic Resection for the Prevention of REcurrent Crohn's DiseaSe (SPARES)
Study description - Patients will be randomized according to post-operative recurrence risk to either a high ligation of ileocolic artery or mesenteric sparing ileocolic resection for terminal ileal Crohn's disease.
- Trial name
- SPARES (NCT04578392)
- Testing
- high ligation of ileocolic artery, mesenteric sparing
- Where
- 7 sites in United States, Canada and 2 more
- Volunteers
- 13 people
- Sponsor
- The Cleveland Clinic
Ulcerative Colitis (UC)
Clinical Trial of Zuoqing SAN in Treating Ulcerative Colitis
The exact efficacy of Zuoqing SAN enema in the treatment of Ulcerative colitis (UC) has been clinically verified. In this study, Zuoqing SAN was used to treat UC patients with large intestine damp-heat syndrome, and the…
- Trial name
- NCT06667934
- Testing
- Zuoqing powder was dissolved in 100ml normal saline, retained enema, once a night, Methalazine suppository was given rectally once a day
- Volunteers
- 60 people
- Sponsor
- The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine
Inflammatory Bowel Diseases
A Safety and Tolerability Study of GSK2982772, in Single (in Both Fed and Fasted States) and Repeat Oral Doses in Healthy Male Subjects
This study is the first administration of GSK2982772 in humans. The study will evaluate the safety, tolerability, pharmacokinetics (PK), and exploratory pharmacodynamics (PD) of single and repeat oral doses of up to 14 days with…
- Trial name
- NCT02302404
- Testing
- GSK2982772 solution, GSK2982772 capsule
- Where
- United Kingdom
- Volunteers
- 79 people, healthy volunteers welcome
- Sponsor
- GlaxoSmithKline
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.